NKG2C/KLRC2 tumor cell expression enhances immunotherapeutic efficacy against glioblastoma. - de Dios O; Ramírez-González MA; Gómez-Soria I; Segura-Collar B; Manosalva J; Megías D; De Andrea CE; Fernández-Rubio L; Hernández-Laín A; Sepúlveda-Sánchez JM; Rodriguez-Ruiz ME; Pérez-Núñez Á; et al. (Journal for immunotherapy of cancer, 2024)